Human AB Serum is an AB serum that is graded for cell culture and can be tailored as per the user's requirements.
Details
Size: 100 mL
Human AB Serum is sourced from healthy male donors of the AB serotype. Both off-the-clot and plasma-derived serum is collected at facilities that follow FDA guidance in the USA. The plasma-derived serum is obtained by converting plasma from Human AB donors through plasmapheresis. The plasma is then converted to serum via defibrination.
In compliance with current FDA requirements, all donor units are screened for viral markers at the collection facility and are determined to be non-reactive. Before being distributed, the finished serum product is subjected to a rigorous quality control testing process.
Key benefits
- BioIVT US-sourced material, using only Male AB donors, meets the health requirements established by 21CFR 610.40 Chapter F, subpart E.
- Human AB serum is a vital cell culture reagent providing growth factors, vitamins and nutrients, as well as trace elements and transport factors ensuring a suitable environment for the propagation of a variety of human cell types.
- Human AB serum has been proven to grow many human cell lines faster and with a smaller percentage of serum required than when using mixed blood type human serum.
- Human AB serum, converted from plasma, is an economical product and more widely available than off-clot serum.
Quality
Specifications
BioIVT adheres to documented procedures governing the sourcing, handling, processing, storage, preservation, packaging, and distribution of products. Additionally, BioIVT's US donor centers are registered with the FDA for Blood and HCT/P and comply with all relevant GMP/GTP standards outlined in 21 CFR Parts 11, 58, 606, and 1271.
Biohazard Information: These products are derived from human tissue. Treat all items containing human-derived materials as potentially infectious, as no known method can give 100% assurance that human-derived materials will not transmit infectious agents. All biological products provided by BioIVT should be handled at Biosafety Level 2, as recommended by the CDC/NHI manual, “Biosafety in Microbiological and Biomedical Laboratories.”